Gene: MB21D2
Official Full Name: Mab-21 domain containing 2provided by HGNC
Gene Summary: Enables cadherin binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21907 | MB21D2 Knockout cell line (HeLa) | Human | MB21D2 | 1:3~1:6 | Negative | Online Inquiry |
KO21908 | MB21D2 Knockout cell line (HCT 116) | Human | MB21D2 | 1:2~1:4 | Negative | Online Inquiry |
KO21909 | MB21D2 Knockout cell line (HEK293) | Human | MB21D2 | 1:3~1:6 | Negative | Online Inquiry |
KO21910 | MB21D2 Knockout cell line (A549) | Human | MB21D2 | 1:3~1:4 | Negative | Online Inquiry |
MB21D2 Gene Knockout Cell Lines are specialized biological tools designed to enable researchers to study the function and regulation of the MB21D2 gene, which is implicated in various cellular processes and diseases. These cell lines have been meticulously engineered using CRISPR-Cas9 technology to create precise gene knockouts, facilitating loss-of-function studies that deepen our understanding of gene function and its associated pathways.
The key mechanism behind the MB21D2 Gene Knockout Cell Lines is the targeted disruption of the MB21D2 gene, leading to a deficiency in its resultant protein. This allows researchers to investigate the biological consequences of gene inactivation, including alterations in cellular behavior, signal transduction, and metabolic profiles. By employing these cell lines, scientists can elucidate the contributions of MB21D2 to processes such as DNA repair, immune response, and oncogenesis, making them invaluable for both basic and applied research.
The scientific importance of these cell lines extends into various domains, including drug development, cancer research, and regenerative medicine. By providing a reliable platform for gene function analysis, MB21D2 Gene Knockout Cell Lines are pivotal in identifying potential therapeutic targets and biomarkers, ultimately accelerating the pace of discovery in translational research.
Compared to traditional methods of gene manipulation, such as RNA interference or chemical inhibitors, the MB21D2 Gene Knockout Cell Lines offer unparalleled specificity and efficiency, thus reducing off-target effects. As a high-fidelity solution, these knockout models provide a robust framework for validation in different experimental conditions.
For researchers and clinicians alike, the value of the MB21D2 Gene Knockout Cell Lines lies in their ability to deliver consistent and reproducible results, which are critical for publishing high-impact findings and advancing therapeutic strategies. Furthermore, leveraging our company’s expertise in cutting-edge gene editing technologies, we ensure that each product meets the highest standards of quality and performance, empowering scientists to transcend the current limits of their research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.